Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD

Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in sto...

Full description

Bibliographic Details
Main Authors: Stephan Buderus, James H. Boone, Michael J. Lentze
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2015/578527